Axsome Therapeutics (AXSM) Net margin US GAAP (year values) |
|||||||||
| 2022 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| Net margin, % | ? | -374.0% | -88.4% | -74.5% | -28.7% | -26.6% | |||
| Changes by years, y/y, % | +286pp | +14pp | +46pp | -57.5% | |||||
Axsome Therapeutics. Net margin, %
Axsome Therapeutics. Net margin, changes, pp
Axsome Therapeutics (AXSM) Net margin US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| Net margin, % | ? | -48.9% | -32.0% | -27.6% | -14.6% | -33.8% | -26.6% | |
| Changes by years, y/y, % | +42pp | +59pp | +34pp | +49pp | +15pp | |||
| Changes by quarters, q/q, % | +14pp | +17pp | +4pp | +13pp | -19pp | |||